[3C3-3C3];[3E2-3E2];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
3C3;3E2
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC531 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC531 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}f04499 and P{XP}d11541 insertion sites are 3C3;3E2.